Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SKYE | Skye Bioscience, Inc. | Chief Executive Officer, Director | $4.22M | Oct 28, 2024 | ||
ARTH | Arch Therapeutics, Inc. | Director | Nov 10, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|